{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:18:57Z","timestamp":1793942337001,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070812"],"award-info":[{"award-number":["82070812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170795"],"award-info":[{"award-number":["82170795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2023QYJC008"],"award-info":[{"award-number":["2023QYJC008"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JC0003"],"award-info":[{"award-number":["2021JC0003"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30762"],"award-info":[{"award-number":["2023JJ30762"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30805"],"award-info":[{"award-number":["2023JJ30805"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jaut.2024.103171","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T12:40:00Z","timestamp":1706791200000},"page":"103171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes"],"prefix":"10.1016","volume":"143","author":[{"given":"Ting","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-7983","authenticated-orcid":false,"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaut.2024.103171_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10138","key":"10.1016\/j.jaut.2024.103171_bib2","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jaut.2024.103171_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142242","article-title":"Type 1 diabetes mellitus: much progress, many opportunities","volume":"131","author":"Powers","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2024.103171_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2017.04.005","article-title":"Lessons learned from twins in autoimmune and chronic inflammatory diseases","volume":"83","author":"Generali","year":"2017","journal-title":"J Autoimmun"},{"issue":"6554","key":"10.1016\/j.jaut.2024.103171_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science"},{"issue":"6554","key":"10.1016\/j.jaut.2024.103171_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jaut.2024.103171_bib7","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.2337\/dc21-2543","article-title":"Glycemic variability patterns strongly correlate with partial remission status in children with newly diagnosed type 1 diabetes","volume":"45","author":"Poll\u00e9","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2024.103171_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.trsl.2019.03.002","article-title":"Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study","volume":"210","author":"Villalba","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.jaut.2024.103171_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.04.012","article-title":"A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes","volume":"166-167","author":"Moya","year":"2016","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2024.103171_bib10","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa130","article-title":"PD-1 and PD-L1 expression in peripheral CD4\/CD8+ T cells is restored in the partial remission phase in type 1 diabetes","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"issue":"8","key":"10.1016\/j.jaut.2024.103171_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jaut.2024.103171_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaut.2024.103171_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaut.2024.103171_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.jaut.2024.103171_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.11.001","article-title":"STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D(hi) CD8(+) T cell dysregulation and accumulation","volume":"55","author":"Masle-Farquhar","year":"2022","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/eji.201948362","article-title":"CD28 and CD57 define four populations with distinct phenotypic properties within human CD8(+) T cells","volume":"50","author":"Pangrazzi","year":"2020","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2024.103171_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10875-008-9213-4","article-title":"Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells","volume":"28","author":"Sun","year":"2008","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cei.13577","article-title":"Exhausted T cells in systemic lupus erythematosus patients in long-standing remission","volume":"204","author":"Lima","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142680","article-title":"Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects","volume":"6","author":"Diggins","year":"2021","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.jaut.2024.103171_bib21","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1172\/JCI120555","article-title":"Autoreactive T effector memory differentiation mirrors \u03b2 cell function in type 1 diabetes","volume":"128","author":"Yeo","year":"2018","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jaut.2024.103171_bib22","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI85996","article-title":"IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection","volume":"126","author":"Younes","year":"2016","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jaut.2024.103171_bib23","article-title":"Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15","volume":"5","author":"Morris","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cid\/civ840","article-title":"CD8 T-Cell expansion and inflammation linked to CMV coinfection in ART-treated HIV infection","volume":"62","author":"Freeman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jaut.2024.103171_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167091","article-title":"Interleukin-15 (IL-15) strongly correlates with increasing HIV-1 viremia and markers of inflammation","volume":"11","author":"Swaminathan","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jaut.2024.103171_bib26","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/cid\/ciw148","article-title":"Cytomegalovirus immunity and exhaustive CD8+ T cell proliferation in treated human immunodeficiency virus infection","volume":"62","author":"Barrett","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jaut.2024.103171_bib27","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/infdis\/jiw463","article-title":"Inflammatory function of CX3CR1+ CD8+ T cells in treated HIV infection is modulated by platelet interactions","volume":"214","author":"Mudd","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaut.2024.103171_bib28","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1038\/ncomms9306","article-title":"Functional classification of memory CD8(+) T cells by CX3CR1 expression","volume":"6","author":"B\u00f6ttcher","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jaut.2024.103171_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-022-01292-5","article-title":"Bifunctional small molecules targeting PD-L1\/CXCL12 as dual immunotherapy for cancer treatment","volume":"8","author":"Cheng","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-020-08793-7","article-title":"Immunobiology of T cells in Sj\u00f6gren's syndrome","volume":"60","author":"Yao","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib32","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaut.2024.103171_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2018.10.004","article-title":"Pathological roles of the homeostatic chemokine CXCL12","volume":"44","author":"Janssens","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"10.1016\/j.jaut.2024.103171_bib34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1136\/annrheumdis-2015-207851","article-title":"Association of chemokine CXC ligand 12 gene polymorphism (rs1746048) with cardiovascular mortality in patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"74","author":"Ibrahim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2024.103171_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2017.10.011","article-title":"Reprint of \"Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis\"","volume":"185","author":"Devarapu","year":"2017","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103171_bib36","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","article-title":"CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus","volume":"182","author":"Wang","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jaut.2024.103171_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.108.141085","article-title":"Blockade of CXCL12\/CXCR4 axis ameliorates murine experimental colitis","volume":"327","author":"Mikami","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.jaut.2024.103171_bib38","doi-asserted-by":"crossref","first-page":"dgaa130","DOI":"10.1210\/clinem\/dgaa130","article-title":"PD-1 and PD-L1 expression in peripheral CD4\/CD8+ T cells is restored in the partial remission phase in type 1 diabetes","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jaut.2024.103171_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3461","article-title":"Three-phasic pattern of C-peptide decline in type 1 diabetes patients with partial remission","volume":"37","author":"Shi","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"10.1016\/j.jaut.2024.103171_bib40","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.jaut.2024.103171_bib41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaut.2024.103171_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109729","article-title":"Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes","author":"Li","year":"2023","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2024.103171_bib43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2017.176701","article-title":"Deep sequencing and flow cytometric characterization of expanded effector memory CD8(+)CD57(+) T cells frequently reveals T-cell receptor V\u03b2 oligoclonality and CDR3 homology in acquired aplastic anemia","volume":"103","author":"Giudice","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jaut.2024.103171_bib44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8(+) CD57(+) T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus","volume":"152","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000639","article-title":"CD8(+)CD57(+) T cells exhibit distinct features in human non-small cell lung cancer","volume":"8","author":"Huang","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.jaut.2024.103171_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/08916934.2018.1477132","article-title":"Features of peripheral CD8(+)CD57(+) lymphocytes in patients with autoimmune hemolytic anemia","volume":"51","author":"Fatone","year":"2018","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaut.2024.103171_bib47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.jaut.2024.103171_bib48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8(+) T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2024.103171_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.jaut.2024.103171_bib50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jaut.2024.103171_bib51","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaut.2024.103171_bib52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/diabetes.50.5.1211","article-title":"A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes","volume":"50","author":"Dubois-Laforgue","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2004.01.005","article-title":"Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications","volume":"26","author":"Yang","year":"2004","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.jaut.2024.103171_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1365-2567.2002.01478.x","article-title":"Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice","volume":"107","author":"Matin","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2024.103171_bib55","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3389\/fimmu.2020.01883","article-title":"CD226 attenuates Treg proliferation via akt and erk signaling in an EAE model","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaut.2024.103171_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2172-9-51","article-title":"Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development","volume":"9","author":"Leng","year":"2008","journal-title":"BMC Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2024.103171_bib57","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.2007.03370.x","article-title":"The CXCR4\/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes","volume":"148","author":"Aboumrad","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2024.103171_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2018.08.011","article-title":"Harnessing CXCL12 signaling to protect and preserve functional \u03b2-cell mass and for cell replacement in type 1 diabetes","volume":"193","author":"Alagpulinsa","year":"2019","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:32:42Z","timestamp":1717803162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":58,"alternative-id":["S0896841124000052"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103171","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103171"}}